2016 Pharmaceutical M&A Scorecard

2016 Pharmaceutical and Biopharmaceutical M&A Scorecard

Merger and acquisition activity is constantly shaping and reshaping the pharmaceutical and biopharmaceutical industries. While 2016 did not go as expected from an M&A perspective what didn’t happen was every bit as important as what did happen.

The 2016 Pharmaceutical & Biopharmaceutical Scorecard includes:

  • What happened and what was expected to happen?
  • Recap of key movements in 2016
  • Detailed scorecard of 2016 M&A activity
  • What’s on the horizon for 2017?